JPWO2020054788A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020054788A5
JPWO2020054788A5 JP2020546064A JP2020546064A JPWO2020054788A5 JP WO2020054788 A5 JPWO2020054788 A5 JP WO2020054788A5 JP 2020546064 A JP2020546064 A JP 2020546064A JP 2020546064 A JP2020546064 A JP 2020546064A JP WO2020054788 A5 JPWO2020054788 A5 JP WO2020054788A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen atom
group
acceptable salt
pharmacologically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020546064A
Other languages
English (en)
Japanese (ja)
Other versions
JP7458987B2 (ja
JPWO2020054788A1 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/035792 external-priority patent/WO2020054788A1/ja
Publication of JPWO2020054788A1 publication Critical patent/JPWO2020054788A1/ja
Publication of JPWO2020054788A5 publication Critical patent/JPWO2020054788A5/ja
Application granted granted Critical
Publication of JP7458987B2 publication Critical patent/JP7458987B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020546064A 2018-09-13 2019-09-12 イミダゾピリジノン化合物 Active JP7458987B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018171839 2018-09-13
JP2018171839 2018-09-13
PCT/JP2019/035792 WO2020054788A1 (ja) 2018-09-13 2019-09-12 イミダゾピリジノン化合物

Publications (3)

Publication Number Publication Date
JPWO2020054788A1 JPWO2020054788A1 (ja) 2021-08-30
JPWO2020054788A5 true JPWO2020054788A5 (https=) 2022-09-14
JP7458987B2 JP7458987B2 (ja) 2024-04-01

Family

ID=69777067

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020546064A Active JP7458987B2 (ja) 2018-09-13 2019-09-12 イミダゾピリジノン化合物

Country Status (24)

Country Link
US (2) US12077531B2 (https=)
EP (1) EP3808747B1 (https=)
JP (1) JP7458987B2 (https=)
KR (1) KR102830577B1 (https=)
CN (1) CN112689637B (https=)
AR (1) AR116400A1 (https=)
AU (1) AU2019340173B2 (https=)
BR (1) BR112021004730A2 (https=)
CA (1) CA3106385A1 (https=)
DK (1) DK3808747T3 (https=)
ES (1) ES3016010T3 (https=)
FI (1) FI3808747T3 (https=)
HU (1) HUE069830T2 (https=)
IL (1) IL281391B2 (https=)
MX (1) MX2021003027A (https=)
MY (1) MY207239A (https=)
NZ (1) NZ773786A (https=)
PH (1) PH12021550512A1 (https=)
PL (1) PL3808747T3 (https=)
PT (1) PT3808747T (https=)
SG (1) SG11202102441VA (https=)
TW (1) TWI814903B (https=)
WO (1) WO2020054788A1 (https=)
ZA (1) ZA202101671B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7414550B2 (ja) * 2020-01-23 2024-01-16 キッセイ薬品工業株式会社 (ヘテロ)アリールイミダゾロン化合物
US20230107927A1 (en) 2020-02-28 2023-04-06 First Wave Bio, Inc. Methods of treating iatrogenic autoimmune colitis
CA3169000A1 (en) * 2020-03-11 2021-09-16 Hideki Takeuchi Crystal of imidazopyridinone compound or salt thereof
JP7654426B2 (ja) * 2020-03-12 2025-04-01 キッセイ薬品工業株式会社 イミダゾピリジノン化合物の製造方法
CN117402178B (zh) * 2023-12-15 2024-03-08 英矽智能科技(上海)有限公司 作为jak抑制剂和phd抑制剂的嘧啶类化合物
WO2025264818A1 (en) * 2024-06-20 2025-12-26 Raythera, Inc. Stat6 modulators and methods of uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0650961B1 (de) * 1993-11-02 1997-03-05 Hoechst Aktiengesellschaft Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
US6713474B2 (en) 1998-09-18 2004-03-30 Abbott Gmbh & Co. Kg Pyrrolopyrimidines as therapeutic agents
CA2344249A1 (en) * 1998-09-18 2000-03-30 Basf Aktiengesellschaft Pyrrolopyrimidines as protein kinase inhibitors
WO2001072751A1 (en) 2000-03-29 2001-10-04 Knoll Gesellschaft Mit Beschraenkter Haftung Pyrrolopyrimidines as tyrosine kinase inhibitors
WO2003037890A2 (en) 2001-11-01 2003-05-08 Icagen, Inc. Piperidines
MXPA06000700A (es) * 2003-07-23 2006-04-11 Wyeth Corp Compuestos de sulfonildihidroimidazopiridinona como ligandos de 5-hidroxitriptamina-6.
US7749999B2 (en) 2003-09-11 2010-07-06 Itherx Pharmaceuticals, Inc. Alpha-ketoamides and derivatives thereof
ATE531705T1 (de) * 2004-05-18 2011-11-15 Schering Corp Substituierte 2-chinolyloxazole geeignet als pde4 inhibitoren
EP1861377B1 (en) 2005-03-15 2010-12-29 Pfizer, Inc. Benzimidazolone derivatives as cb2 receptor ligands
DE102005019712A1 (de) 2005-04-28 2006-11-09 Bayer Healthcare Ag Dipyridyl-dihydropyrazolone und ihre Verwendung
WO2007015877A2 (en) * 2005-07-20 2007-02-08 Kalypsys, Inc. Inhibitors of p38 kinase and methods of treating inflammatory disorders
US20070142369A1 (en) 2005-12-21 2007-06-21 Margaret Van Heek Combination of an H3 antagonist/inverse agonist and an appetite suppressant
US20090298811A1 (en) 2006-09-12 2009-12-03 Pfizer Inc Benzimidazolone derivatives
EP2160187B1 (en) 2007-05-16 2013-05-22 Merck Sharp & Dohme Corp. Spiroindalones
CA2686485A1 (en) * 2007-05-23 2008-11-27 Pharmacopeia, Llc Purinones and 1h-imidazopyridinones as pkc-theta inhibitors
CA2698071A1 (en) 2007-08-27 2009-03-05 Wyeth Llc Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
CN101951777A (zh) * 2008-02-25 2011-01-19 默沙东公司 四氢呋喃并吡啶酮
EP2294066B9 (en) 2008-04-28 2015-03-11 Janssen Pharmaceutica, N.V. Benzoimidazoles as prolyl hydroxylase inhibitors
EP2285375B1 (en) 2008-05-08 2013-04-10 Merck Sharp & Dohme Corp. spiroazaindole compounds as HIF propylhydroxylase inhibitors
EP2364313B1 (en) 2008-09-09 2014-01-08 Boehringer Ingelheim International GmbH Aza-benzimidazolone chymase inhibitors
SI2455381T1 (sl) * 2009-07-17 2014-08-29 Japan Tobacco Inc. Triazolopiridinova spojina in njeno delovanje kot zaviralec prolil-hidroksilaze in induktor produkcije eritropoietina
JP2011037814A (ja) 2009-08-14 2011-02-24 Synstar Japan Co Ltd マラリア原虫疾患予防又は治療用の5−ヘテロ環置換イミノ−9−ジアルキルアミノベンゾ[a]フェノキサチン化合物又はその塩とアーテミシニン誘導体との組み合わせ
WO2011096490A1 (ja) 2010-02-04 2011-08-11 第一三共株式会社 イミダゾピリジン-2-オン誘導体
FR2967355B1 (fr) * 2010-11-17 2013-09-27 Jouvin Jean Luc Seringue dentaire securisee
WO2014181813A1 (ja) 2013-05-10 2014-11-13 武田薬品工業株式会社 複素環化合物
EP3056975B1 (en) 2013-10-08 2020-08-12 Maxell, Ltd. Projection type image display device, manipulation detection device and projection type image display method
WO2015052675A1 (en) 2013-10-10 2015-04-16 Glenmark Pharmaceuticals S.A. Substituted dihydro-benzimidazole compounds as ror gamma modulators
CN104926733B (zh) 2014-03-18 2019-05-10 北京韩美药品有限公司 作为RORγ调节剂的化合物
GB201504565D0 (en) * 2015-03-18 2015-05-06 Takeda Pharmaceutical Novel compounds
UA124090C2 (uk) * 2015-06-03 2021-07-21 Прінсіпіа Байофарма Інк. Інгібітори тирозинкінази
EP3414234B1 (en) 2015-10-14 2022-06-29 Zibo Biopolar Changsheng Pharmaceutical Co. Ltd. Bruton's tyrosine kinase inhibitors
RU2743126C9 (ru) 2016-08-22 2021-04-27 Шицзячжуан Сагесити Нью Драг Дивелопмент Ко., Лтд. Ингибитор pde4
US10899758B2 (en) * 2016-09-16 2021-01-26 Vitae Pharmaceuticals, Llc Inhibitors of the menin-MLL interaction
CA3087886A1 (en) * 2018-01-19 2019-07-25 Idorsia Pharmaceuticals Ltd C5a receptor modulators

Similar Documents

Publication Publication Date Title
JPWO2020054788A5 (https=)
JP2019514874A5 (https=)
JP2019104748A5 (https=)
JP2017537940A5 (https=)
JP2016520618A5 (https=)
JP2016518328A5 (https=)
JP2016540742A5 (https=)
JP2011037841A5 (https=)
JP2010504286A5 (https=)
JP2016518437A5 (https=)
JP2015143283A5 (https=)
JP2012524056A5 (https=)
JP2015522650A5 (https=)
JP2016501250A5 (https=)
JP2013542218A5 (https=)
JP2016536363A5 (https=)
JP2013543842A5 (https=)
JP2010510999A5 (https=)
JP2010155827A5 (https=)
JP2010501478A5 (https=)
JP2018528244A5 (https=)
JP2019512535A5 (https=)
JP2020511547A5 (https=)
JP2020504434A5 (https=)
JP2016512547A5 (https=)